Health
Full intensity heparin has value in treating hospitalized COVID-19 patients – News-Medical.Net
Results from the RAPID clinical trial suggest heparin may lower the risk of death from moderate COVID-19 infection by 78%. Heparin…
Heparin is typically administered for blood clotting, but its anti-inflammatory and anti-viral effects have captured interest as a potential COVID-19 treatment. An international team of researchers led by Peter Jüni of St. Michael’s Hospital and the University…
Continue Reading
-
Noosa News10 hours agoPrincess Anne visits Gallipoli Barracks in Brisbane on Remembrance Day as Australian tour ends
-
General7 hours agoCar bomb outside Islamabad court kills at least five, Pakistani media says
-
General19 hours agoHungarian British author David Szalay wins Booker Prize 2025 for his novel Flesh
-
General21 hours agoMillennials and Gen Z voters continued shift away from Coalition in 2025